Article Details
Retrieved on: 2021-02-15 09:45:00
Tags for this article:
Click the tags to see associated articles and topics
Excerpt
New phase III data show Roche's faricimab is the first investigational injectable eye medicine to extend time between treatments up to four months in ...
Article found on: pharmafield.co.uk
This article is found inside other hiswai user's workspaces. To start your own collection, sign up for free.
Sign UpAlready have an account? Log in here